title: Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. 2-4 April 2004, Naarden, The Netherlands.
authors.affiliation: Institute of Human Genetics, International Centre for Life, Central Parkway, Newcastle upon Tyne NE3 4YQ, UK. kate.bushby@ncl.ac.uk
authors.forename: K
authors.initials: K
authors.lastname: Bushby
authors.forename: F
authors.initials: F
authors.lastname: Muntoni
authors.forename: A
authors.initials: A
authors.lastname: Urtizberea
authors.forename: R
authors.initials: R
authors.lastname: Hughes
authors.forename: R
authors.initials: R
authors.lastname: Griggs
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D002309:Cardiology; D006801:Humans; D007391:International Cooperation; D020388:Muscular Dystrophy, Duchenne / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care / Q000592:standards*; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones